| 2191 |
GRAVINATE TABLET 50 MG |
DIMENHYDRINATE BP 50 MG |
TABLET |
ALU-PVC BLISTER |
USED FOR TREATING VERTIGO, MOTION SICKNESS ANS NAUSEA ASSOCIATED WITH PREGNANCY |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5508/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 2192 |
IROPAL |
IRON PROTEIN SUCCINYLAT 800 MG /15 ML (EQ.TO ELEMENTAL IRON 40 MG) |
SYRUP |
BOTTLE |
IRON PROTEIN SUCCINYLATE IS PRIMARILY INDICATED IN CONDITIONS LIKE IRON DEFICIENCY ANEMIA. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4183/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2193 |
JENTIN |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG |
FILM-COATED TABLETS |
ALU-BLISTER |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS, IN PATIENTS WITH TYPE 2 DIABETES TO IMPROVE GLYCEMIC CONTROL IN COMBINATION WITH METFORMIN OR A PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST WHEN THE SINGLE AGENT ALONE, WITH DIET AND EXCERCISE, DOES NOT PROVIDE ADEQUATE GLYCEMIC CONTROL |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 4865/19 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 2194 |
JENTIN |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 100 MG |
FILM-COATED TABLETS |
ALU-BLISTER |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS, IN PATIENTS WITH TYPE 2 DIABETES TO IMPROVE GLYCEMIC CONTROL IN COMBINATION WITH METFORMIN OR A PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST WHEN THE SINGLE AGENT ALONE, WITH DIET AND EXCERCISE, DOES NOT PROVIDE ADEQUATE GLYCEMIC CONTROL |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 4864/19 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 2195 |
JENTIN MET |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG, METFORMIN HCL 500 MG |
FILM-COATED TABLETS |
ALU-BLISTER |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH BOTH SITAGLIPTIN AND METFORMIN IS APPROPRIATE |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 4867/19 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 2196 |
JENTIN MET |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG, METFORMIN HCL 1000 MG |
FILM-COATED TABLETS |
ALU-BLISTER |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH BOTH SITAGLIPTIN AND METFORMIN IS APPROPRIATE |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 4866/19 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 2197 |
LEVOBRAN 500 |
LEVOFLOXACIN HEMIHYDRATE USP EQ.TO LEVOFLOXACIN ANHYDROUS 500 MG |
FILM-COATED TABLETS |
STRIP |
ACUTE BACTERIAL SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SOFT TISSUE INFECTIONS, CHRONIC BACTERIAL PROSTATITIS |
NULL |
POUNSAB PHARMA CO.,LTD |
BRAWN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
10 I 4600/18 |
06-DEC-2022 |
05-DEC-2025 |
View |
| 2198 |
MASTIC-LC TABLETS |
MONTELUKAST 10 MG, LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG |
TABLET |
ALU-ALU BLISTER |
RELIEF OF SYMPTOMS OF ALLERGIC RHINITIS( SEASONAL OR PERENNIAL), AS PROPHYLAXIS IN SEASONAL ALLERGIC RHINITIS AND TREATMENT OF COMORBID ASTHMA AND ALLERGIC RHINITIS IN PATIENTS 15 YEARS OF AGE AND OVER |
NULL |
POUNSAB PHARMA CO.,LTD |
BRAWN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
01 I 4641/19 |
06-DEC-2022 |
05-DEC-2025 |
View |
| 2199 |
MEFSTAN 500 |
MEFENAMIC ACID BP 500 MG |
FILM-COATED TABLETS |
STRIP |
FOR THE SYMPTOMATIC RELIEF OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, AND PAIN INCLUDING MUSCULAR, TRAUMATIC AND DENTAL PAIN,HEADACHE; PRIMARY DYSMENORRHOEA |
NULL |
POUNSAB PHARMA CO.,LTD |
BRAWN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
10 I 4594/18 |
06-DEC-2022 |
05-DEC-2025 |
View |
| 2200 |
METHARAN |
BETAMETHASONE SODIUM PHOSPHATE BP 0.1 %W/V, THIOMERSAL BP 0.005 % W/V |
EYE DROPS |
BOTTLE |
INFLAMMATORY CONDITIONS OF THE EAR SUCH AS OTITIS EXTERNA; HAY FEVER , VASOMOTOR AND NON SEASONAL ALLERGIC RHINITIS,NON -INFECTED INFLAMMATORY CONDITIONS SUCH AS NON SPECIFIC KERATIS, CONJUNCTIVAL ALLERGIES |
NULL |
POUNSAB PHARMA CO.,LTD |
BRAWN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
04 I 4671/19 |
06-DEC-2022 |
05-DEC-2025 |
View |
